Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Psoriasis? 287 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 287 reports of Psoriasis have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 3.1% of all adverse event reports for CYCLOBENZAPRINE.

287
Reports of Psoriasis with CYCLOBENZAPRINE
3.1%
of all CYCLOBENZAPRINE reports
125
Deaths
25
Hospitalizations

How Dangerous Is Psoriasis From CYCLOBENZAPRINE?

Of the 287 reports, 125 (43.6%) resulted in death, 25 (8.7%) required hospitalization, and 25 (8.7%) were considered life-threatening.

Is Psoriasis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOBENZAPRINE. However, 287 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Psoriasis?

SECUKINUMAB (21,976) APREMILAST (19,255) ADALIMUMAB (16,698) ETANERCEPT (10,818) RISANKIZUMAB-RZAA (6,896) METHOTREXATE (6,283) USTEKINUMAB (4,955) INFLIXIMAB (3,524) CERTOLIZUMAB PEGOL (3,428) IXEKIZUMAB (2,818)

Which CYCLOBENZAPRINE Alternatives Have Lower Psoriasis Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Psoriasis Reports All Drugs Causing Psoriasis CYCLOBENZAPRINE Demographics